Nectar Social | $10,600,000 | (Jun 6, 2025)
Baobab | $13,702,071 | (Jun 6, 2025)
Signify Bio | $15,000,000 | (Jun 6, 2025)
Avenda Health
United States
- Culver City, California
- 30/08/2022
- Series B
- $10,000,000
1 in 7 men will be diagnosed with prostate cancer in their lifetime, and the current standard of care in treatment significantly impairs quality of life due to imprecision.
Avenda Health is creating a more personalized future of prostate cancer care. We've built a platform that uses deep learning to map a patient's cancer in 3D, giving physicians precise information and the confidence to make care decisions. This is paired with a proprietary targeted ablative therapy that can treat patients in a doctors office under local anesthesia. Avenda Health aims to improve outcomes, preserve quality of life, and create a new standard of cancer care.
- Industry Medical Equipment Manufacturing
- Website https://avendahealth.com/
- LinkedIn https://www.linkedin.com/company/avenda-health/
Related People
Shyam NatarajanCo Founder
United States -
Los Angeles, California
Focused on improving clinical outcomes and patient care in urology and beyond.
Leading a clinical-stage AI healthcare startup that is creating a more personalized future of prostate cancer care. Previously led an NIH-funded lab focusing on image-guided cancer interventions at UCLA with a background in software engineering.
Voltrac | $2,286,772 | (Jun 6, 2025)
Rosebud | $6,000,000 | (Jun 6, 2025)
Allay Therapeutics | $57,500,000 | (Jun 6, 2025)
Impart Security | $12,000,000 | (Jun 6, 2025)
Flank | $10,000,000 | (Jun 6, 2025)
Obvio | $22,000,000 | (Jun 5, 2025)
Filament Syfter | $4,800,000 | (Jun 5, 2025)
Vivrelle | $62,000,000 | (Jun 5, 2025)
Sema4.ai | $25,000,000 | (Jun 5, 2025)